Choy EH - Search Results

1

Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation Requirements.

Humby F, Kelly S, Bugatti S, Manzo A, Filer A, Mahto A, Fonseca JE, Lauwerys B, D'Agostino MA, Naredo E, Lories R, Montecucco C, Tak PP, Fitzgerald O, Smith MD, Veale DJ, Choy EH, Strand V, Pitzalis C. Humby F, et al. Among authors: choy eh. J Rheumatol. 2016 Jan;43(1):208-13. doi: 10.3899/jrheum.141199. Epub 2015 Jun 1. J Rheumatol. 2016. PMID: 26034155 Review.

2

Monoclonal antibody therapy in rheumatic disease.

Pitzalis C, Choy E, Kingsley G. Pitzalis C, et al. Presse Med. 1994 Mar 19;23(11):532-9. Presse Med. 1994. PMID: 8022742 Review.

3

Synovial fluid lymphocyte proliferation to tuberculin protein product derivative: a novel way of diagnosing tuberculous arthritis.

Choy EH, Chieco-Bianchi F, Panayi GS, Kingsley GH. Choy EH, et al. Clin Exp Rheumatol. 1994 Mar-Apr;12(2):187-90. Clin Exp Rheumatol. 1994. PMID: 8039287

4

Fourth International Symposium on the Immunotherapy of the Rheumatic Diseases. 21-25 May 1997, Cyprus.

Pitzalis C, Choy E. Pitzalis C, et al. Ann Rheum Dis. 1998 Mar;57(3):1779. Ann Rheum Dis. 1998. PMID: 9660717 No abstract available.

5

The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.

Choy EH, Schantz A, Pitzalis C, Kingsley GH, Panayi GS. Choy EH, et al. Br J Rheumatol. 1998 Jul;37(7):801-2. doi: 10.1093/rheumatology/37.7.801. Br J Rheumatol. 1998. PMID: 9714366 Clinical Trial. No abstract available.

6

The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis.

Choy EH, Rankin EC, Kassimos D, Vetterlein O, Garyfallos A, Ravirajan CT, Sopwith M, Eastell R, Kingsley GH, Isenberg DA, Panayi GS. Choy EH, et al. J Rheumatol. 1999 Nov;26(11):2310-7. J Rheumatol. 1999. PMID: 10555883 Clinical Trial.

7

Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.

Choy EH, Scott DL, Kingsley GH, Williams P, Wojtulewski J, Papasavvas G, Henderson E, Macfarlane D, Erhardt C, Young A, Plant MJ, Panayi GS. Choy EH, et al. Clin Exp Rheumatol. 2002 May-Jun;20(3):351-8. Clin Exp Rheumatol. 2002. PMID: 12102471 Clinical Trial.

8

Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial.

Choy EH, Hazleman B, Smith M, Moss K, Lisi L, Scott DG, Patel J, Sopwith M, Isenberg DA. Choy EH, et al. Rheumatology (Oxford). 2002 Oct;41(10):1133-7. doi: 10.1093/rheumatology/41.10.1133. Rheumatology (Oxford). 2002. PMID: 12364632 Clinical Trial.

9

Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.

Kingsley GH, Khoshaba B, Smith CM, Choy EH, Scott DL. Kingsley GH, et al. Among authors: choy eh. Rheumatology (Oxford). 2005 May;44(5):629-32. doi: 10.1093/rheumatology/keh565. Epub 2005 Feb 10. Rheumatology (Oxford). 2005. PMID: 15705630

10

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL. Choy EH, et al. Rheumatology (Oxford). 2005 Nov;44(11):1414-21. doi: 10.1093/rheumatology/kei031. Epub 2005 Jul 19. Rheumatology (Oxford). 2005. PMID: 16030080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters